Use of a Physiologically based Pharmacokinetic – Pharmacodynamic Model to Account for Adjustments to dosing of S-warfarin in Different Populations Poster Use of a Physiologically based Pharmacokinetic – Pharmacodynamic Model to Account for Adjustments to dosing of S-warfarin in Different Populations Danielle Pillsbury2019年9月3日
Quantitative description of the physiological changes in diseased skin and their incorporation into Physiologically Based Pharmacokinetic Models. ポスター Quantitative description of the physiological changes in diseased skin and their incorporation into Physiologically Based Pharmacokinetic Models. Danielle Pillsbury2019年9月3日
Predicting Diffusion in the Dermis: a Physiologically Based, Bottom-up Approach Poster Predicting Diffusion in the Dermis: a Physiologically Based, Bottom-up Approach Danielle Pillsbury2019年9月3日
Modeling in vitro skin permeation experiments to mechanistically understand in vivo dermal absorption: Application of in vitro-in vivo extrapolation (IVIVE) and physiological based pharmacokinetic (PBPK) modeling using testosterone as model drug Poster Modeling in vitro skin permeation experiments to mechanistically understand in vivo dermal absorption: Application of in vitro-in vivo extrapolation (IVIVE) and physiological based pharmacokinetic (PBPK) modeling using testosterone as model drug Danielle Pillsbury2019年9月3日
Assessing the Bioequivalence of Tacrolimus Amorphous Formulations with Varying Degrees of Crystallinity using Mechanistic Dissolution Models in a Population Physiologically-based Pharmacokinetic (PBPK) Modelling Framework Poster Assessing the Bioequivalence of Tacrolimus Amorphous Formulations with Varying Degrees of Crystallinity using Mechanistic Dissolution Models in a Population Physiologically-based Pharmacokinetic (PBPK) Modelling Framework Danielle Pillsbury2019年9月3日
Application of Feto-Placental-Maternal Physiologically-based Pharmacokinetic Model to Predict Tenofovir Concentration during Pregnancy Poster Application of Feto-Placental-Maternal Physiologically-based Pharmacokinetic Model to Predict Tenofovir Concentration during Pregnancy Danielle Pillsbury2019年9月3日
Development of a Physiologically Based Pharmacokinetic Model of Buspirone and Its Active Metabolite 1-(2-Pyrimidinyl)-Piperazine to Estimate Drug-Drug Interaction and Food Effect Poster Development of a Physiologically Based Pharmacokinetic Model of Buspirone and Its Active Metabolite 1-(2-Pyrimidinyl)-Piperazine to Estimate Drug-Drug Interaction and Food Effect Danielle Pillsbury2019年9月3日
Physiologically-based pharmacokinetic modeling of the effect of chronic kidney disease on the pharmacokinetics of drugs eliminated nonrenally Poster Physiologically-based pharmacokinetic modeling of the effect of chronic kidney disease on the pharmacokinetics of drugs eliminated nonrenally Danielle Pillsbury2019年9月3日
A comparison of two model reduction methodologies for a QSP bone biology system with denosumab dosing Poster A comparison of two model reduction methodologies for a QSP bone biology system with denosumab dosing Danielle Pillsbury2019年9月3日
Prediction of Plasma, Tissue and in vitro Cell Exposure of CS4 Chemicals Using IVIVE-PBPK and Biokinetic Models Poster Prediction of Plasma, Tissue and in vitro Cell Exposure of CS4 Chemicals Using IVIVE-PBPK and Biokinetic Models Danielle Pillsbury2019年9月3日
